BioSig Technologies Inc (NASDAQ:BSGM) has announced the signing of a new agreement for the clinical evaluation of the company’s PURE EP technology for arrhythmia care at Medical City North Hills in North Richland Hills, Texas.
As part of the evaluation agreement, Medical City North Hills clinical representatives will provide on-site training and assist with data collection and interpretation and workflow customization for every physician and all electrophysiology lab staff members to ensure optimal user experience.
“We are pleased to start conducting patient cases at another outstanding hospital in Texas. With over 400 electrophysiology labs, the state of Texas is home to some of the greatest cardiac care facilities in our country,” BioSig CEO Kenneth Londoner said in a statement.
READ: BioSig installs PURE EP system at New York hospital as part of northeast commercial launch
“We look forward to collaborating with the physician team at Medical City North Hills as we continue to advance and expand upon our clinical and commercial strategy,” Londoner added.
PURE EP is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.
The company noted that Texas is one of the three strategic areas that BioSig is focused on in the targeted commercial launch phase, alongside the Northeast and Florida.
PURE EP technology is currently installed at several clinical sites in Texas, including Houston Methodist Hospital.
BioSig added that more than 50 physicians have completed over 1000 patient cases with the PURE EP System across 12 clinical sites.
Contact Sean at sean@proactiveinvestors.com